Compounds > oxycodone

oxycodone and Drug Withdrawal Symptoms

oxycodone has been researched along with Drug Withdrawal Symptoms in 53 studies

Research

Studies (53)

TimeframeStudies, this research(%)All Research%
pre-19905 (9.43)18.7374
1990's1 (1.89)18.2507
2000's9 (16.98)29.6817
2010's19 (35.85)24.3611
2020's19 (35.85)2.80

Authors

AuthorsStudies
Applebey, SV; Bossert, JM; Duan, Y; Fredriksson, I; Lu, H; Shaham, Y; Shekara, A; Tsai, PJ; Yang, Y1
Hohmann, AG; Iyer, V; Pacheco, R; Woodward, TJ1
Bateman, BT; Esposito, DB; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Straub, L; Werler, MM1
Candy, B; Jones, L; Larkin, PJ; Stone, P; Vickerstaff, V1
Al-Hasani, R; Baldwin, JW; Conway, SM; Dougherty, JD; Madasu, MK; Maloney, SE; McCullough, KB; Mikati, MO; Minakova, E; Swift, RG1
Milovanovic, M; Stefanik, MT; Wolf, ME; Wong, B; Zimbelman, AR1
Amgott-Kwan, AT; Zadina, JE1
Azani, D; Barahona, JA; Barrera, M; Cahill, CM; Dong, TS; Hakimian, JK; Jacobs, JP; Lagishetty, V; Lee, S; Mittal, N; Severino, AL; Tiwari, S; Walwyn, WM1
Acevedo-Canabal, A; Bannister, TD; Bohn, LM; Cameron, MD; Grim, TW; Ho, JH; Kennedy, NM; Pantouli, F; Schmid, CL; Stahl, EL1
Ashizawa, K; Hara, T; Ikeda, T; Ishii, K; Kamada, M; Komatsu, Y; Matsuo, K; Morishita, S; Ryu, E; Yamaguchi, M; Yamashita, H1
Hill, MR; Hopkins, MR; Knezevic, CE1
Bergman, J; Doyle, RJ; Kangas, BD; Porter, EN; Withey, SL1
Barr, GA; DeSalle, MJ; Deutsch, HM; Eisch, AJ; Zanni, G1
Conlisk, D; de Guglielmo, G; George, O; Kallupi, M; Kimbrough, A; Kononoff, J; Momper, JD; Palomino, K; Sedighim, S; Simpson, S1
Coma, E; González-Barboteo, J; Moreno, D; Olmo, M; Serrano, G1
Blendy, JA; Butelman, ER; Collins, D; Kreek, MJ; Zhang, Y1
Chartoff, E; Constantino, N; Lintz, T; Mavrikaki, M; Page, S1
Hodes, GE; Kumar, M; Lile, JA; Rainville, JR; Turner, JR; Vassoler, FM; Williams, K1
Barr, GA; DeSalle, MJ; Deutsch, HM; Dougher, AA; Eisch, AJ; Robinson-Drummer, PA; Sullivan, RM; Teplitsky, D; Vemulapalli, A; Zanni, G1
Beardsley, PM; Carper, M; Contreras, KM; Damaj, MI; Walentiny, DM1
Aguilar, L; Álvarez-Navares, A; Casado-Espada, N; Gamonal-Limcaoco, S; Grau-López, L; Lozano-López, MT; Roncero, C; Vicente-Hernández, B1
Brown, CN; Coelho, MA; Healy, AF; Jimenez, SM; Kippin, TE; Szumlinski, KK1
Allen, RP; Earley, CJ; Foster, K; Hiranniramol, K; Skeba, P; Wang, A1
Blackwood, CA; Cadet, JL; Leary, M; McCoy, MT; Salisbury, A1
Casado-Espada, NM; De Alarcón, R; De La Iglesia-Larrad, JI; Fernández-Martín, LC; Fombellida, CI; Martín, C; Roncero, C1
Bruera, E; Kang, JH; Lee, GW; Shin, SH1
Brigham, G; Cameron, D; Carlson, R; Daniulaityte, R; Sheth, A1
Gangahar, D1
Graudins, A; Greene, SL; Koutsogiannis, Z; Macleod, D; Robinson, J; Wong, A1
Dahmke, H; Kullak-Ublick, GA; Kupferschmidt, H; Weiler, S1
Babalonis, S; Elayi, SC; Jicha, CJ; Lofwall, MR; Nuzzo, PA; Walsh, SL1
Beardsley, PM; Walentiny, DM; Wiebelhaus, JM1
Briyal, S; Devarapalli, M; Gulati, A; Leonard, M; Puppala, BL; Schweig, L; Stefanov, G1
Koizumi, T; Mamiya, K; Sakamoto, A; Takayama, H1
Babalonis, S; Casselton, V; Lofwall, MR; Nuzzo, PA; Walsh, SL1
Babalonis, S; Elayi, SC; Lofwall, MR; Nuzzo, PA; Walsh, SL1
Fishman, M1
Berkelhammer, DL; Brzeski, A; Coats, BD; Crysdale, NY; Hutchinson, MR; Johnson, KW; Judd, CM; Lewis, SS; Maier, SF; Northcutt, A; Skyba, DA; Vietz, CM; Watkins, LR1
Wilcock, A1
Gould, EM; Peniston, JH; Xiang, Q1
Carmichael, JP; Lee, MA1
Almeida, PG; Huttner, KM; Moran, LR; Worden, S1
Burns, LH; Olmstead, MC1
Bazari, H; Linshaw, M; Takayesu, JK1
Collins, RJ1
Bresnahan, JF; Fritz, KD; Horlocker, TT; Kinney, MO; Lewallen, DG; Locketz, AJ; Prasad, A; Rivera, JM1
Burns, LH; Butera, PG; Friedmann, N; Moran, LV; Webster, LR; Wu, N1
Charney, DS; Kleber, HD1
Gardos, G1
Goldstein, E; Lazoritz, M; Pollack, R; Weiner, B1
Bruun, R; Kurlan, R1
Fishbain, DA; Goldberg, M; Rosomoff, H; Rosomoff, RS1
Naulty, JS; Weintraub, SJ1

Reviews

2 review(s) available for oxycodone and Drug Withdrawal Symptoms

ArticleYear
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    The Cochrane database of systematic reviews, 2022, 09-15, Volume: 9

    Topics: Adult; Analgesics, Opioid; Child; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Induced Constipation; Oxycodone; Palliative Care; Quaternary Ammonium Compounds; Substance Withdrawal Syndrome

2022
Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: a systematic review.
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:13

    Topics: Analgesics, Opioid; Buprenorphine; Heroin; Humans; Methadone; Morphine; Oxycodone; Psychotic Disorders; Substance Withdrawal Syndrome; Tramadol

2021

Trials

4 trial(s) available for oxycodone and Drug Withdrawal Symptoms

ArticleYear
Safety of oral dronabinol during opioid withdrawal in humans.
    Drug and alcohol dependence, 2015, Dec-01, Volume: 157

    Topics: Administration, Oral; Adolescent; Adult; Analgesics, Opioid; Blood Pressure; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Heart Rate; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Pupil; Substance Withdrawal Syndrome; Tachycardia, Sinus; Treatment Outcome; Young Adult

2015
Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.
    Drug and alcohol dependence, 2016, May-01, Volume: 162

    Topics: Administration, Intranasal; Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Young Adult

2016
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans.
    Drug and alcohol dependence, 2016, Jul-01, Volume: 164

    Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome; Young Adult

2016
Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
    The journal of pain, 2006, Volume: 7, Issue:12

    Topics: Adolescent; Adult; Aged; Analgesics; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Naltrexone; Oxycodone; Pain Measurement; Substance Withdrawal Syndrome; Treatment Outcome

2006

Other Studies

47 other study(ies) available for oxycodone and Drug Withdrawal Symptoms

ArticleYear
Orbitofrontal cortex and dorsal striatum functional connectivity predicts incubation of opioid craving after voluntary abstinence.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 10-26, Volume: 118, Issue:43

    Topics: Analgesics, Opioid; Animals; Corpus Striatum; Magnetic Resonance Imaging; Male; Motivation; Oxycodone; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome

2021
A limited access oral oxycodone paradigm produces physical dependence and mesocorticolimbic region-dependent increases in DeltaFosB expression without preference.
    Neuropharmacology, 2022, 03-01, Volume: 205

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Disease Models, Animal; Locomotion; Mice; Naloxone; Narcotic Antagonists; Nociception; Nucleus Accumbens; Opioid-Related Disorders; Oxycodone; Proto-Oncogene Proteins c-fos; Substance Withdrawal Syndrome

2022
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    JAMA network open, 2022, 08-01, Volume: 5, Issue:8

    Topics: Adult; Analgesics, Opioid; Codeine; Cohort Studies; Female; Humans; Hydrocodone; Hydromorphone; Infant, Newborn; Infant, Newborn, Diseases; Methadone; Morphine; Neonatal Abstinence Syndrome; Oxycodone; Pain; Pregnancy; Prescriptions; Substance Withdrawal Syndrome; Tramadol; United States

2022
Perinatal oxycodone exposure causes long-term sex-dependent changes in weight trajectory and sensory processing in adult mice.
    Psychopharmacology, 2022, Volume: 239, Issue:12

    Topics: Analgesics, Opioid; Animals; Body-Weight Trajectory; Female; Humans; Infant, Newborn; Male; Mice; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Oxycodone; Perception; Pregnancy; Substance Withdrawal Syndrome

2022
GluA2-lacking AMPA receptors in the nucleus accumbens core and shell contribute to the incubation of oxycodone craving in male rats.
    Addiction biology, 2022, Volume: 27, Issue:6

    Topics: Animals; Cocaine; Craving; Male; Nucleus Accumbens; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Self Administration; Substance Withdrawal Syndrome

2022
Endomorphin analog ZH853 shows low reward, tolerance, and affective-motivational signs of withdrawal, while inhibiting opioid withdrawal and seeking.
    Neuropharmacology, 2023, 04-01, Volume: 227

    Topics: Analgesics, Opioid; Animals; Female; Humans; Male; Mice; Morphine; Narcotics; Opioid-Related Disorders; Oxycodone; Rats; Reward; Substance Withdrawal Syndrome

2023
Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Opioid-Seeking Behaviors and Alters the Gut Microbiome.
    Nutrients, 2019, Aug-14, Volume: 11, Issue:8

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Brain; Dietary Supplements; Disease Models, Animal; Drug-Seeking Behavior; Fatty Acids, Omega-3; Gastrointestinal Microbiome; Male; Mice, Inbred C57BL; Microglia; Opioid-Related Disorders; Oxycodone; Recurrence; Substance Withdrawal Syndrome

2019
A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020, Volume: 45, Issue:2

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Female; Guanosine 5'-O-(3-Thiotriphosphate); Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Oxycodone; Pain Measurement; Receptors, Opioid, mu; Substance Withdrawal Syndrome

2020
Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis.
    Internal medicine (Tokyo, Japan), 2020, Jan-15, Volume: 59, Issue:2

    Topics: Analgesics, Opioid; Breast Neoplasms; Cancer Pain; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Oxycodone; Substance Withdrawal Syndrome

2020
Emerging Toxidromes: A 25-Year-Old Woman with Syncope and ECG Changes.
    Clinical chemistry, 2019, Volume: 65, Issue:11

    Topics: Adult; Electrocardiography; Female; Humans; Loperamide; Opioid-Related Disorders; Oxycodone; Self Medication; Substance Withdrawal Syndrome; Syncope

2019
Discrimination learning in oxycodone-treated nonhuman primates.
    Drug and alcohol dependence, 2020, 02-01, Volume: 207

    Topics: Analgesics, Opioid; Animals; Discrimination Learning; Dose-Response Relationship, Drug; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Primates; Saimiri; Self Administration; Substance Withdrawal Syndrome

2020
Female and male rats readily consume and prefer oxycodone to water in a chronic, continuous access, two-bottle oral voluntary paradigm.
    Neuropharmacology, 2020, 05-01, Volume: 167

    Topics: Administration, Oral; Analgesics, Opioid; Animals; Choice Behavior; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Male; Opioid-Related Disorders; Oxycodone; Rats; Rats, Long-Evans; Self Administration; Sex Characteristics; Substance Withdrawal Syndrome; Water

2020
Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats.
    Psychopharmacology, 2020, Volume: 237, Issue:5

    Topics: Analgesics, Opioid; Animals; Brain; Emotions; Female; Male; Oxycodone; Pain Threshold; Rats; Rats, Wistar; Self Administration; Sex Characteristics; Substance Withdrawal Syndrome

2020
Acute opioid withdrawal syndrome from naloxone/naloxegol interaction.
    BMJ supportive & palliative care, 2021, Volume: 11, Issue:4

    Topics: Analgesics, Opioid; Constipation; Humans; Male; Morphinans; Naloxone; Narcotic Antagonists; Oxycodone; Polyethylene Glycols; Substance Withdrawal Syndrome

2021
Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration.
    Neuropharmacology, 2020, 12-15, Volume: 181

    Topics: Animals; Corpus Striatum; Female; Gene Knock-In Techniques; Genotype; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Narcotics; Nucleus Accumbens; Oxycodone; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Self Administration; Sex Characteristics; Substance Abuse, Intravenous; Substance Withdrawal Syndrome

2020
Chronic opioid exposure differentially modulates oxycodone self-administration in male and female rats.
    Addiction biology, 2021, Volume: 26, Issue:3

    Topics: Animals; Female; Male; Morphine; Narcotics; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome

2021
Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal.
    Neuropharmacology, 2021, 03-15, Volume: 186

    Topics: Analgesics, Opioid; Animals; Female; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Neuroimmunomodulation; Oxycodone; Prefrontal Cortex; Sex Characteristics; Substance Withdrawal Syndrome

2021
Maternal continuous oral oxycodone self-administration alters pup affective/social communication but not spatial learning or sensory-motor function.
    Drug and alcohol dependence, 2021, 04-01, Volume: 221

    Topics: Administration, Oral; Affect; Analgesics, Opioid; Animals; Animals, Newborn; Behavior, Animal; Communication; Disease Models, Animal; Female; Male; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Oxycodone; Pregnancy; Pregnancy Complications; Rats; Self Administration; Spatial Learning; Substance Withdrawal Syndrome

2021
Validation and characterization of oxycodone physical dependence in C57BL/6J mice.
    European journal of pharmacology, 2021, Jul-15, Volume: 903

    Topics: Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice, Inbred C57BL; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Substance Withdrawal Syndrome

2021
Variability in prescription opioid intake and reinforcement amongst 129 substrains.
    Genes, brain, and behavior, 2017, Volume: 16, Issue:7

    Topics: Analgesics, Opioid; Animals; Fentanyl; Genetic Variation; Heroin; Male; Mice; Opioid-Related Disorders; Oxycodone; Reinforcement, Psychology; Substance Withdrawal Syndrome

2017
Assessment of change in restless legs syndrome symptoms during the acute drug-withdrawal period.
    Sleep medicine, 2018, Volume: 52

    Topics: Analgesics; Analgesics, Opioid; Dopamine Agonists; Electromyography; Female; Gabapentin; Humans; Indoles; Male; Middle Aged; Oxycodone; Polysomnography; Pramipexole; Restless Legs Syndrome; Substance Withdrawal Syndrome

2018
Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving.
    Neuroscience, 2019, 09-01, Volume: 415

    Topics: Animals; Behavior, Addictive; Corpus Striatum; Craving; Fibroblast Growth Factors; Genes, Immediate-Early; Male; Models, Animal; Nucleus Accumbens; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Self Administration; Substance Withdrawal Syndrome

2019
Psychotic symptoms following oxycodone withdrawal, case report and update.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:14

    Topics: Adult; Antipsychotic Agents; Humans; Male; Oxycodone; Psychotic Disorders; Substance Withdrawal Syndrome; Treatment Outcome

2019
Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis.
    Journal of pain and symptom management, 2013, Volume: 46, Issue:2

    Topics: Abdominal Pain; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Portal Vein; Stomach Neoplasms; Substance Withdrawal Syndrome; Treatment Outcome; Venous Thrombosis

2013
"Sub is a weird drug:" A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms.
    The American journal on addictions, 2015, Volume: 24, Issue:5

    Topics: Adult; Attitude to Health; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Female; Health Surveys; Humans; Hydrocodone; Internet; Middle Aged; Opioid-Related Disorders; Oxycodone; Self Medication; Substance Withdrawal Syndrome; Treatment Outcome

2015
A case of rhabdomyolysis associated with severe opioid withdrawal.
    The American journal on addictions, 2015, Volume: 24, Issue:5

    Topics: Acute Kidney Injury; Administration, Intranasal; Administration, Oral; Administration, Sublingual; Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Intensive Care Units; Male; Opioid-Related Disorders; Oxycodone; Oxymorphone; Prescription Drugs; Rhabdomyolysis; Self Medication; Substance Withdrawal Syndrome; Young Adult

2015
Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.
    Clinical toxicology (Philadelphia, Pa.), 2015, Volume: 53, Issue:8

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Analgesics, Opioid; Child; Child, Preschool; Databases, Factual; Drug Combinations; Female; Humans; Incidence; Infant; Injections, Intravenous; Male; Middle Aged; Naloxone; Narcotic Antagonists; Oxycodone; Poison Control Centers; Risk Factors; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Tablets; Victoria; Young Adult

2015
[Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
    Praxis, 2015, Oct-14, Volume: 104, Issue:21

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Alcoholism; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pharmacovigilance; Substance Withdrawal Syndrome

2015
Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.
    The Journal of pharmacology and experimental therapeutics, 2016, Volume: 356, Issue:1

    Topics: Animals; Brain; Dose-Response Relationship, Drug; Drug Tolerance; Electrodes, Implanted; Infusions, Subcutaneous; Male; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Self Stimulation; Substance Withdrawal Syndrome

2016
Prenatal Oxycodone Exposure Alters CNS Endothelin Receptor Expression in Neonatal Rats.
    Drug research, 2016, Volume: 66, Issue:5

    Topics: Abnormalities, Drug-Induced; Analgesics, Opioid; Animals; Animals, Newborn; Blotting, Western; Body Weight; Brain; Female; Male; Oxycodone; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Substance Withdrawal Syndrome

2016
Opioid withdrawal presenting only nausea during tapering of oxycodone after celiac plexus block: a case report.
    Annals of palliative medicine, 2016, Volume: 5, Issue:1

    Topics: Aged; Analgesics, Opioid; Autonomic Nerve Block; Back Pain; Celiac Plexus; Humans; Male; Nausea; Oxycodone; Pancreatic Neoplasms; Substance Withdrawal Syndrome; Tomography, X-Ray Computed

2016
Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Addiction (Abingdon, England), 2008, Volume: 103, Issue:8

    Topics: Adolescent; Analgesics, Opioid; Delayed-Action Preparations; Female; Heroin Dependence; Humans; Metabolic Clearance Rate; Naltrexone; Narcotic Antagonists; Oxycodone; Patient Acceptance of Health Care; Substance Withdrawal Syndrome

2008
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
    Brain, behavior, and immunity, 2009, Volume: 23, Issue:2

    Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Brain; Bronchodilator Agents; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Immunohistochemistry; Injections, Intraperitoneal; Male; Minocycline; Morphine; Naloxone; Opioid-Related Disorders; Oxycodone; Pain; Pain Measurement; Pyridines; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Weight Loss

2009
Prolonged-release naloxone can cause systemic opioid withdrawal.
    European journal of pain (London, England), 2009, Volume: 13, Issue:9

    Topics: Analgesics, Opioid; Delayed-Action Preparations; Diarrhea; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Humans; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Patient Compliance; Practice Patterns, Physicians'; Substance Withdrawal Syndrome

2009
Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis.
    Current medical research and opinion, 2010, Volume: 26, Issue:8

    Topics: Aged; Analgesics, Opioid; Chronic Disease; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Oxycodone; Oxymorphone; Pain Measurement; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Treatment Outcome

2010
Symptoms of opioid withdrawal syndrome after switch from oxycodone to alfentanil.
    Journal of pain and symptom management, 2010, Volume: 40, Issue:6

    Topics: Alfentanil; Analgesics, Opioid; Carcinoma, Squamous Cell; Female; Humans; Hyperhidrosis; Lung Neoplasms; Middle Aged; Oxycodone; Pain; Substance Withdrawal Syndrome

2010
Intrauterine baclofen exposure: a multidisciplinary approach.
    Pediatrics, 2004, Volume: 114, Issue:2

    Topics: Analgesics, Opioid; Baclofen; Breast Feeding; Female; GABA Agonists; Humans; Infant, Newborn; Muscle Relaxants, Central; Oxycodone; Pregnancy; Pregnancy Complications; Reflex Sympathetic Dystrophy; Substance Withdrawal Syndrome

2004
Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
    Psychopharmacology, 2005, Volume: 181, Issue:3

    Topics: Animals; Avoidance Learning; Conditioning, Classical; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Morphine Dependence; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Orientation; Oxycodone; Rats; Rats, Sprague-Dawley; Reward; Substance Withdrawal Syndrome

2005
Case records of the Massachusetts General Hospital. Case 7-2006. A 47-year-old man with altered mental status and acute renal failure.
    The New England journal of medicine, 2006, Mar-09, Volume: 354, Issue:10

    Topics: Acid-Base Equilibrium; Acidosis; Acute Kidney Injury; Blood Chemical Analysis; Consciousness Disorders; Diagnosis, Differential; Ethylene Glycol; Humans; Male; Middle Aged; Oxycodone; Poisoning; Seizures; Substance Withdrawal Syndrome; Suicide, Attempted; Urine

2006
Medication sleuth: an important role for pharmacists in determining the etiology of delirium.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2006, Volume: 21, Issue:4

    Topics: Aged; Delirium; Diagnosis, Differential; Drug Overdose; Female; Hospitalization; Humans; Hypnotics and Sedatives; Medical History Taking; Narcotics; Oxycodone; Patient Care Team; Pharmacists; Pyridines; Substance Withdrawal Syndrome; Zolpidem

2006
"Broken heart syndrome" after separation (from OxyContin).
    Mayo Clinic proceedings, 2006, Volume: 81, Issue:6

    Topics: Analgesics, Opioid; Arthroplasty, Replacement, Knee; Cardiomyopathies; Female; Humans; Middle Aged; Osteoarthritis; Oxycodone; Perioperative Care; Substance Withdrawal Syndrome; Syndrome; Ventricular Dysfunction, Left

2006
Iatrogenic opiate addiction: successful detoxification with clonidine.
    The American journal of psychiatry, 1980, Volume: 137, Issue:8

    Topics: Clonidine; Codeine; Female; Humans; Middle Aged; Opioid-Related Disorders; Oxycodone; Pain, Intractable; Substance Withdrawal Syndrome

1980
Dyskinesia after discountinuation of compound analgesic containing oxycodone.
    Lancet (London, England), 1977, Apr-02, Volume: 1, Issue:8014

    Topics: Aspirin; Caffeine; Codeine; Drug Combinations; Female; Humans; Middle Aged; Movement Disorders; Oxycodone; Pain, Postoperative; Phenacetin; Substance Withdrawal Syndrome

1977
Rapid treatment of percodan addiction: a case report.
    The International journal of the addictions, 1978, Volume: 13, Issue:6

    Topics: Adult; Codeine; Drug Administration Schedule; Hospitalization; Humans; Male; Oxycodone; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors

1978
Opiate therapy and self-harming behavior in Tourette's syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Oxycodone; Self Mutilation; Substance Withdrawal Syndrome; Tourette Syndrome

1991
Atypical withdrawal syndrome (organic delusional syndrome) secondary to oxycodone detoxification.
    Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:6

    Topics: Codeine; Delusions; Female; Humans; Middle Aged; Opioid-Related Disorders; Oxycodone; Substance Withdrawal Syndrome; Substance-Related Disorders

1988
Acute abstinence syndrome after epidural injection of butorphanol.
    Anesthesia and analgesia, 1985, Volume: 64, Issue:4

    Topics: Adult; Anesthesia, Epidural; Aspirin; Blood Pressure; Butorphanol; Caffeine; Cesarean Section; Codeine; Drug Combinations; Female; Humans; Morphinans; Nausea; Oxycodone; Phenacetin; Pregnancy; Reoperation; Substance Withdrawal Syndrome

1985